Drug companies increasingly frustrated with the Government over surging NHS clawbacks
Drug companies increasingly frustrated with the Government over surging NHS clawbacks
Copy link
AstraZeneca pauses £200m Cambridge investment
AstraZeneca pauses $270 million investment in Britain
Big pharma firms have paused nearly £2bn in UK investments this year
How the UK fell out with big pharma
Pharma firms pile pressure on the UK as Trump's drug pricing order looms
US urged UK to offer better drug pricing deal to pharma companies
Merck scraps £1bn expansion in the UK over lack of state investment
